United States

People: ImmunoGen Inc (IMGN.OQ)

IMGN.OQ on NASDAQ Stock Exchange Global Select Market

22 Feb 2017
Change (% chg)

$0.00 (+0.00%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Lambert, John 

Dr. John M. Lambert, Ph.D., is Executive Vice President - Distinguished Research Fellow of ImmunoGen, Inc., effective January 5, 2015. He joined ImmunoGen in 1987, and has served as our Executive Vice President and Chief Scientific Officer since July 2008. Prior to that he served in various capacities of increasing responsibility in the areas of research and development. Dr. Lambert holds a Ph.D. in Biochemistry from University of Cambridge in England, and completed his postdoctoral work at the University of California at Davis and at Glasgow University in Scotland.

Basic Compensation

Total Annual Compensation, USD 552,108
Restricted Stock Awards, USD --
Long-Term Incentive Plans, USD --
All Other, USD 633,202
Fiscal Year Total, USD 1,185,310

Options Compensation

  Quantity Market Value
Exercisable 470,168 233,621.00
Unexercisable 69,999 --
Exercised 35,000 349,605.00